{
  "_id": "680249fc3ccffd1c7912c750",
  "ipo_id": "2024_emcure_pharmaceuticals_limited_ipo",
  "__v": 0,
  "_metadata": {
    "sectionsAvailable": {
      "basicDetails": true,
      "tentativeSchedule": true,
      "lotSize": true,
      "timeline": false,
      "kpi": true,
      "financials": true,
      "promoterHolding": true,
      "objectives": false,
      "about": true,
      "subscriptionStatus": true,
      "contactDetails": true,
      "registrarDetails": true,
      "leadManagers": true,
      "listingDetails": true,
      "listingDayTrading": true,
      "faqs": true,
      "recommendationSummary": true,
      "prospectusLinks": true,
      "reservation": true,
      "anchorInvestors": true
    },
    "scrapedAt": "2025-04-18T12:27:23.605Z",
    "sourceUrl": "https://www.chittorgarh.com/ipo/emcure-pharma-ipo/1766/"
  },
  "about": {
    "details": "<p>Incorporated in 1981, Emcure Pharmaceuticals Limited, an Indian pharmaceutical company, develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas.</p>\n<p>The company has been ranked 13th in domestic sales among pharmaceutical companies in India for MAT September 2023 and 4th in market share in its covered markets for the same period. Additionally, it is the leading pharmaceutical company in gynaecology and HIV antiviral therapeutic areas for the MAT September 2023.</p>\n<p>In the six months ended September 30, 2023, and the Financial Year 2023, sales in India contributed 50.84% and 53.16% of the company's total revenue, respectively. The company's Domestic sales grew at a CAGR of 10.80% between September 2019 and September 2023, outperforming the Indian pharmaceutical market.</p>\n<p>As of September 30, 2023, Emcure Pharma employed 552 scientists and operated five research facilities in India. They filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. They had 201 granted patents, 33 pending patent applications, and submitted 102 drug master files.</p>\n<p>Emcure Pharmaceuticals has 13 manufacturing facilities in India. These facilities can produce various pharmaceutical and biopharmaceutical products, including pills, liquids, injectables, and complex ingredients such as chiral molecules, iron molecules, and cytotoxic substances.</p>\n<p>As of September 30, 2023, the company's marketing and distribution network in India was supported by over 5,000 field personnel who regularly interacted with healthcare providers. The distribution network included over 5,000 stockists, served by 37 carry-and-forward agents.</p>"
  },
  "additionalTables": [
    {
      "heading": "Emcure Pharmaceuticals Limited Financial Information (Restated Consolidated)",
      "sanitizedHeading": "financials",
      "headers": [
        "Period Ended",
        "31 Mar 2024",
        "31 Mar 2023",
        "31 Mar 2022"
      ],
      "rows": [
        [
          "Assets",
          "7806.16",
          "6672.53",
          "6063.47"
        ],
        [
          "Revenue",
          "6715.24",
          "6031.72",
          "5918.86"
        ],
        [
          "Profit After Tax",
          "527.58",
          "561.85",
          "702.56"
        ],
        [
          "Net Worth",
          "2952.28",
          "2501.13",
          "1987.55"
        ],
        [
          "Reserves and Surplus",
          "2722.40",
          "2293.77",
          "1791.03"
        ],
        [
          "Total Borrowing",
          "2091.94",
          "2202.42",
          "2102.19"
        ]
      ]
    },
    {
      "heading": "Emcure Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "emcure_pharmaceuticals_stock_quote_charts",
      "headers": [
        "KPI",
        "Values"
      ],
      "rows": [
        [
          "ROE",
          "16.90%"
        ],
        [
          "ROCE",
          "19.37%"
        ],
        [
          "Debt/Equity",
          "0.67"
        ],
        [
          "RoNW",
          "16.87%"
        ],
        [
          "Price to Book Value",
          "6.18"
        ]
      ]
    },
    {
      "heading": "Emcure Pharmaceuticals Limited Stock Quote & Charts",
      "sanitizedHeading": "emcure_pharmaceuticals_stock_quote_charts",
      "headers": [
        null,
        "Pre IPO",
        "Post IPO"
      ],
      "rows": [
        [
          "EPS (Rs)",
          "29.17",
          "27.95"
        ],
        [
          "P/E (x)",
          "34.55",
          "36.07"
        ]
      ]
    }
  ],
  "anchorInvestors": {
    "summary": "Emcure Pharma IPO raises Rs 582.61 crore from anchor investors. Emcure Pharma IPO Anchor bid date is July 2 2024. Emcure Pharma IPO Anchor Investors list",
    "list_link": {
      "text": "Emcure Pharma IPO Anchor Investors list",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/emcure_pharmaceuticals_anchorallocationreport.pdf"
    },
    "details": {
      "ipo_date": "October 6 2024",
      "shares_offered": "5779850",
      "anchor_portion_size": "582.61"
    }
  },
  "basicDetails": {
    "ipoDate": "July 3, 2024 to July 5, 2024",
    "ipoListingDate": "Wed, Jul 10, 2024",
    "faceValue": "₹10 per share",
    "issuePrice": "₹1,008.00",
    "lotSize": "14 Shares",
    "issueSize": "1,93,65,346 shares (aggregating up to ₹1,952.03 Cr)",
    "freshIssue": "79,36,507 shares (aggregating up to ₹800.00 Cr)",
    "offerForSale": "1,14,28,839 shares of ₹10 (aggregating up to ₹1,152.03 Cr)",
    "issueType": "Bookbuilding IPO",
    "listingAt": "BSE, NSE",
    "ipoOpenDate": "Wed, Jul 3, 2024",
    "ipoCloseDate": "Fri, Jul 5, 2024",
    "initiationOfRefunds": "Tue, Jul 9, 2024",
    "creditOfSharesToDemat": "Tue, Jul 9, 2024",
    "shareHoldingPreIssue": "18,08,52,116 shares",
    "shareHoldingPreIssueAll": [
      {
        "label": "Share Holding Pre Issue",
        "value": "18,08,52,116 shares"
      },
      {
        "label": "Share Holding Pre Issue",
        "value": "98.90%"
      }
    ],
    "shareHoldingPostIssue": "18,87,88,623 shares",
    "shareHoldingPostIssueAll": [
      {
        "label": "Share Holding Post Issue",
        "value": "18,87,88,623 shares"
      },
      {
        "label": "Share Holding Post Issue",
        "value": "78.24%"
      }
    ]
  },
  "closing_date": "2024-07-04T18:30:00.000Z",
  "contactDetails": {
    "phone": "+91 20 3507 0033",
    "email": "investors@emcure.co.in",
    "full_address": "Emcure Pharmaceuticals Limited, Plot No. P-1 and P-2, IT-BT Park Phase II M.I.D.C., Hinjawadi Pune -411 057",
    "website": "https://www.emcure.com/"
  },
  "createdAt": "2025-04-18T12:47:56.580Z",
  "faqs": [
    {
      "question": "What is the Emcure Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Emcure Pharma IPO<!-- --> is a <b>main-board<!-- --> <!-- -->IPO<!-- --> of <!-- -->19365346<!-- --> equity shares</b> of the face value of ₹<!-- -->10<!-- --> aggregating up to ₹<!-- -->1,952.03<!-- --> Crores. The issue is priced at <span>₹1008 per share</span>. The minimum order quantity is <!-- -->14<!-- -->.</p><p>The <!-- -->IPO<!-- --> <b>opens on <!-- -->July 3, 2024</b>, and <b>closes on <!-- -->July 5, 2024</b>.</p><p>Link Intime India Private Ltd<!-- --> is the registrar for the <!-- -->IPO<!-- -->. The shares are proposed to be listed on <!-- -->BSE, NSE<!-- -->.</p></div>"
    },
    {
      "question": "How to apply in Emcure Pharma IPO through Zerodha?",
      "answer": "<div itemprop=\"text\"><p>Zerodha customers can apply online in <!-- -->Emcure Pharma IPO<!-- --> using UPI as a payment gateway. Zerodha customers can apply in <!-- -->Emcure Pharma IPO<!-- --> by login into Zerodha Console (back office) and submitting an IPO application form.</p><p><strong>Steps to apply in <!-- -->Emcure Pharma IPO<!-- --> through Zerodha</strong></p><ol><li>Visit the Zerodha website and login to Console.</li><li>Go to Portfolio and click the IPOs link.</li><li>Go to the '<!-- -->Emcure Pharma IPO<!-- -->' row and click the 'Bid' button.</li><li>Enter your UPI ID, Quantity, and Price.</li><li>Submit IPO application form.</li><li>Visit the UPI App (net banking or BHIM) to approve the mandate.</li></ol><p>Visit <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Application Process Review\">Zerodha IPO Application Process Review</a> for more detail.</p></div>"
    },
    {
      "question": "When Emcure Pharma IPO will open?",
      "answer": "<div itemprop=\"text\"><p>The Emcure Pharma IPO opens on July 3, 2024 and closes on July 5, 2024.</p></div>"
    },
    {
      "question": "What is the lot size of Emcure Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>Emcure Pharma IPO<!-- --> <b>lot size is <!-- -->14</b>, and the <b>minimum amount required is <span>₹14,112</span></b>.</p></div>"
    },
    {
      "question": "How to apply for Emcure Pharma IPO?",
      "answer": "<div itemprop=\"text\"><p>You can apply in <!-- -->Emcure Pharma IPO<!-- --> online using either <a href=\"/article/upi-payment-option-ipo-application-explained/382/\">UPI</a> or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through <a href=\"/broker/zerodha/ipo/18/\" title=\"Zerodha IPO Review\"><b>Zerodha</b></a>, <a href=\"/broker/upstox/ipo/33/\" title=\"Upstox IPO Review\">Upstox</a>, <a href=\"/broker/5paisa/ipo/4/\" title=\"5Paisa IPO Review\">5Paisa</a>, <a href=\"/broker/edelweiss_broking/ipo/34/\" title=\"Nuvama IPO Review\">Nuvama</a>, <a href=\"/broker/hdfc-securities/ipo/6/\" title=\"HDFC Bank IPO Review\">HDFC Bank</a>, and <a href=\"/broker/sbi-capital/ipo/19/\" title=\"SBI Capital IPO Review\">SBI Bank</a>.</p></div>"
    },
    {
      "question": "When is Emcure Pharma IPO allotment?",
      "answer": "<div itemprop=\"text\"><p>The finalization of Basis of Allotment for <!-- -->Emcure Pharma IPO<!-- --> will be done on <!-- -->Monday, July 8, 2024<!-- -->, and the allotted shares will be credited to your demat account by <!-- -->Tuesday, July 9, 2024<!-- -->. Check the <a href=\"/ipo_allotment_status/emcure-pharma-ipo/1766/\" title=\"Emcure Pharma IPO Allotment Status\">Emcure Pharma IPO<!-- --> allotment status</a>.</p></div>"
    },
    {
      "question": "When is Emcure Pharma IPO listing date?",
      "answer": "<div itemprop=\"text\"><p>The <!-- -->Emcure Pharma IPO<!-- --> listing date is on <b>Wednesday, July 10, 2024</b>.</p></div>"
    }
  ],
  "ipoName": "Emcure Pharmaceuticals",
  "issue_price": "₹1,008.00",
  "issue_price_numeric": 1,
  "issue_size": "1,93,65,346 shares (aggregating up to ₹1,952.03 Cr)",
  "issue_size_numeric": 1,
  "leadManagerReports": [
    {
      "text": "IPO Lead Manager Performance Summary",
      "url": "/report/ipo_lead_manager_performance_tracker/19/"
    },
    {
      "text": "IPO Lead Manager Performance Tracker",
      "url": "/report/ipo-lead-manager-vs-listing-gain/99/17/"
    }
  ],
  "leadManagers": [
    {
      "name": "Kotak Mahindra Capital Company Limited",
      "url": "/report/ipo-lead-manager-review/112/12/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/12/"
    },
    {
      "name": "Axis Capital Limited",
      "url": "/report/ipo-lead-manager-review/112/113/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/113/"
    },
    {
      "name": "J.P. Morgan India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/19/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/19/"
    },
    {
      "name": "Jefferies India Private Limited",
      "url": "/report/ipo-lead-manager-review/112/112/",
      "performance_link": "/report/ipo-lead-manager-vs-listing-gain/99/112/"
    }
  ],
  "listingDayTrading": {
    "data": {
      "final_issue_price": {
        "bse": "1008.00",
        "nse": "1008.00"
      },
      "open": {
        "bse": "1325.05",
        "nse": "1325.05"
      },
      "low": {
        "bse": "1325.05",
        "nse": "1325.05"
      },
      "high": {
        "bse": "1384.00",
        "nse": "1385.00"
      },
      "last_trade": {
        "bse": "1358.85",
        "nse": "1359.15"
      }
    },
    "performance_link": {
      "text": "Check IPO Performance…",
      "url": "/ipo/ipo_perf_tracker.asp"
    }
  },
  "listingDetails": {
    "pre_open_links": [
      {
        "text": "Pre-Open Session - NSE",
        "url": "https://www.nseindia.com/market-data/new-stock-exchange-listings-today"
      },
      {
        "text": "Pre-Open Session - BSE",
        "url": "https://www.bseindia.com/eqstreamer/StockTickerSplPreOpen.html"
      }
    ],
    "ipo_date": "July 10 2024",
    "bse_script_code": "544210",
    "nse_symbol": "EMCURE",
    "isin": "INE168P01015",
    "final_issue_price": "1008 per share"
  },
  "listing_date": "2024-07-09T18:30:00.000Z",
  "listing_gains": "34.81%",
  "listing_gains_numeric": 34.81,
  "logo": "https://www.chittorgarh.net/images/ipo/emcure_pharma_logo.png",
  "logo_url": "https://www.chittorgarh.net/images/ipo/emcure_pharma_logo.png",
  "lotSize": {
    "summary": "Investors can bid for a minimum of 14 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.",
    "applications": {
      "retail_min": {
        "application": "Retail (Min)",
        "lots": "1",
        "shares": "14",
        "amount": "14112"
      },
      "retail_max": {
        "application": "Retail (Max)",
        "lots": "14",
        "shares": "196",
        "amount": "197568"
      },
      "shni_min": {
        "application": "S-HNI (Min)",
        "lots": "15",
        "shares": "210",
        "amount": "211680"
      },
      "shni_max": {
        "application": "S-HNI (Max)",
        "lots": "70",
        "shares": "980",
        "amount": "987840"
      },
      "bhni_min": {
        "application": "B-HNI (Min)",
        "lots": "71",
        "shares": "994",
        "amount": "1001952"
      },
      "lot_size": {
        "application": "Lot Size Calculator"
      }
    },
    "calculator_link": {
      "text": "Lot Size Calculator",
      "url": "/ipo-hni-funding-cost-calculator/emcure-pharma-ipo/1766/"
    }
  },
  "lot_size": 14,
  "opening_date": "2024-07-02T18:30:00.000Z",
  "pageHeading": "Emcure Pharmaceuticals Limited IPO (Emcure Pharma IPO) Detail",
  "pageTitle": "Emcure Pharma IPO Date, Price, GMP, Review, Details",
  "promoterHolding": {
    "promoters": "Satish Mehta and Sunil Mehta are the company promoters.",
    "holdings": {
      "share_holding_pre_issue": "98.90%",
      "share_holding_post_issue": "78.24%"
    },
    "note": "The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue"
  },
  "prospectusLinks": [
    {
      "text": "Emcure Pharma IPO DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/dec-2023/emcure-pharmaceuticals-limited-drhp_80072.html"
    },
    {
      "text": "Emcure Pharma IPO Addendum DRHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/mar-2024/emcure-pharmaceuticals-limited-addendum-to-drhp_82408.html"
    },
    {
      "text": "Emcure Pharma IPO RHP",
      "url": "https://www.sebi.gov.in/filings/public-issues/jun-2024/emcure-pharmaceuticals-limited-rhp_84516.html"
    },
    {
      "text": "Anchor Investors in Emcure Pharma IPO",
      "url": "https://www.chittorgarh.net/reports/anchor-investor/emcure_pharmaceuticals_anchorallocationreport.pdf"
    }
  ],
  "recommendationSummary": {
    "recommendations": {
      "brokersbrokers": {
        "subscribe": "18",
        "neutral": "0",
        "avoid": "0"
      },
      "membersmembers": {
        "subscribe": "2",
        "neutral": "0",
        "avoid": "0"
      }
    },
    "links": [
      {
        "text": "Read All Reviews",
        "url": "/ipo-recommendation/emcure-pharma-ipo/1766/"
      },
      {
        "text": "Post Your Review",
        "url": "#"
      },
      {
        "text": "Manage Reviews",
        "url": "#"
      }
    ]
  },
  "registrarDetails": {
    "name": "Link Intime India Private Ltd",
    "phone": "+91-22-4918 6270",
    "email": "emcure.ipo@linkintime.co.in",
    "website": "https://linkintime.co.in/Initial_Offer/public-issues.html"
  },
  "reservation": {
    "summary": "Emcure Pharma IPO offers 19483388 shares. 3853234 (19.78%) to QIB 2889926 (14.83%) to NII 6743160 (34.61%) to RII 108900 (0.56%) to employees and 5779850 (29.67%) to Anchor investors. 481654 RIIs will receive minimum 14 shares and 4587 (sNII) and 9174 (bNII) will receive minimum 210 shares. (in case of oversubscription)",
    "allocation": [
      {
        "investor_category": "Anchor Investor Shares Offered",
        "shares_offered": "5779850 (29.67%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "QIB Shares Offered",
        "shares_offered": "3853234 (19.78%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "NII (HNI) Shares Offered",
        "shares_offered": "2889926 (14.83%)"
      },
      {
        "investor_category": "bNII > 10L",
        "shares_offered": "1926618 (9.89%)",
        "maximum_allottees": "9174"
      },
      {
        "investor_category": "sNII < 10L",
        "shares_offered": "963309 (4.94%)",
        "maximum_allottees": "4587"
      },
      {
        "investor_category": "Retail Shares Offered",
        "shares_offered": "6743160 (34.61%)",
        "maximum_allottees": "481654"
      },
      {
        "investor_category": "Employee Shares Offered",
        "shares_offered": "108900 (0.56%)",
        "maximum_allottees": "NA"
      },
      {
        "investor_category": "Total Shares Offered",
        "shares_offered": "19483388 (100%)"
      }
    ]
  },
  "scraped_at": "2025-04-18T12:47:56.580Z",
  "source_url": "",
  "status": "listed",
  "subscriptionStatus": {
    "summary": "The Emcure Pharma IPO is subscribed 67.87 times on July 5 2024 6:20:06 PM (Day 3). The public issue subscribed 7.36 times in the retail category 191.24 times in the QIB category and 49.32 times in the NII category. Check Day by Day Subscription Details (Live Status)",
    "overall": {
      "qib": {
        "category": "QIB",
        "subscription_times": "191.24",
        "shares_offered": "3853234",
        "shares_bid_for": "736891932"
      },
      "nii": {
        "category": "NII",
        "subscription_times": "49.32",
        "shares_offered": "2889926",
        "shares_bid_for": "142525866"
      },
      "bnii": {
        "category": "bNII (bids above 10L)",
        "subscription_times": "54.9",
        "shares_offered": "1926618",
        "shares_bid_for": "105770490"
      },
      "snii": {
        "category": "sNII (bids below 10L)",
        "subscription_times": "38.16",
        "shares_offered": "963309",
        "shares_bid_for": "36755376"
      },
      "retail": {
        "category": "Retail",
        "subscription_times": "7.36",
        "shares_offered": "6743160",
        "shares_bid_for": "49618884"
      },
      "employee": {
        "category": "Employee",
        "subscription_times": "8.81",
        "shares_offered": "108900",
        "shares_bid_for": "959756"
      },
      "total": {
        "category": "Total",
        "subscription_times": "67.87",
        "shares_offered": "13703538",
        "shares_bid_for": "929996438"
      }
    },
    "total_applications": "2845226"
  },
  "tentativeDetails": {
    "ipo_date": "5 PM on July 5 2024",
    "tentative_allotment": "Mon Jul 8 2024",
    "initiation_of_refunds": "Tue Jul 9 2024",
    "credit_of_shares_to_demat": "Tue Jul 9 2024"
  },
  "updatedAt": "2025-04-19T04:43:47.415Z",
  "updated_at": "2025-04-18T12:47:56.580Z",
  "year": 2024,
  "worst_listing_gains": "34.81%",
  "worst_listing_gains_numeric": 34.81,
  "last_performance_update": "2025-04-19T04:43:47.415Z"
}